This is an interview with Uri Lee, CEO of Xcell Therapeutics. Xcell is an international leader in serum-free, chemically defined media. In this interview, we discuss the mission and purpose of Xcell Therapeutics, its product development pipeline, its rapid growth, and the company’s future goals. Enjoy. [Read more…]
Decoding Biological Aging: Is Age Just a Number?
The relentless march of time is an inescapable fact, but its effects on our overall well-being are profound and intricate. Referred to by some experts as the “master disease”, aging is more than merely growing older. It represents the functional decline of a living organism over time. This article probes into the multifaceted nature of biological aging, its repercussions, and the innovative ways in which science is demystifying and even countering its challenges. [Read more…]
Nucleus Biologics Becomes First Custom Cell Culture Media Company to Achieve EXCiPACT Certification for the Manufacture of Excipient GMP Quality Cell Culture Media, Supplements, and Buffers
San Diego, CA, January 9, 2025 – Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, reagents, and supplements needs for our cell and gene therapy customers. This certification, in addition to our ISO 13485 certification, underscores Nucleus Biologics’ commitment to delivering the highest quality products that meet the most stringent safety, consistency, and compliance requirements of the biopharmaceutical industry. [Read more…]
Restoration of Whole-Person Health: Re-envisioning Global Access
Scientists increasingly agree that the convergence of advanced longevity technologies and regenerative medicines offers great promise for chronic disease prevention and optimal health throughout the individual’s lifespan. Thought leaders in these fields lament that in the rapidly evolving medical landscape, the journey from groundbreaking research to practical application is often fraught with challenges. HEALinc, a future health research and development (R&D) organization founded by Dr. Desirée Cox, is dedicated to overcoming the “Valley of Death” hurdle and ensuring that life-changing, longevity-enhancing therapies reach those who need them most. [Read more…]
The Dominance of Cell and Gene Therapy CDMOS in 2025
While there are many exciting market segments, the market for cell and gene therapy CDMO services is one of the most fascinating. A decade ago, there were only a handful of market competitors. Today, there are more than a hundred companies specializing in manufacturing and clinical trial support for cell and gene therapies (CGT)—and demand for their services continues to rise. [Read more…]
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 60
- Next Page »